Module 5 Product Risk Assessment General Approaches

[Pages:37]Q3D training module 5 Risk Assessment

Module 5

Product Risk Assessment General Approaches

ICH Q3D Elemental Impurities

Disclaimer: This presentation includes the authors' views on Elemental Impurities theory and practice. The presentation does not represent official guidance or policy of authorities or industry.

International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use

Prepared by the Q3D Implementation Working Group for example only; not an official policy/guidance ? ICH 2015

1

Q3D training module 5 Risk Assessment

Legal Notice

This presentation is protected by copyright and may be used, reproduced, incorporated into other works, adapted, modified, translated or distributed under a public license provided that ICH's copyright in the presentation is acknowledged at all times. In case of any adaption, modification or translation of the presentation, reasonable steps must be taken to clearly label, demarcate or otherwise identify that changes were made to or based on the original presentation. Any impression that the adaption, modification or translation of the original presentation is endorsed or sponsored by the ICH must be avoided.

The presentation is provided "as is" without warranty of any kind. In no event shall the ICH or the authors of the original presentation be liable for any claim, damages or other liability arising from the use of the presentation.

The above-mentioned permissions do not apply to content supplied by third parties. Therefore, for documents where the copyright vests in a third party, permission for reproduction must be obtained from this copyright holder.

Prepared by the Q3D Implementation Working Group for example only; not an official policy/guidance ? ICH 2015

2

Q3D training module 5 Risk Assessment

Purpose

? To provide an overview of an elemental impurities risk

assessment for a product consistent with ICH Q3D.

? To provide illustrative examples for developing product risk

assessments

o Other approaches may also be acceptable

? The information presented here does not provide new

guidance, rather, it elaborates on how the recommendations in the guidance may be implemented

Prepared by the Q3D Implementation Working Group for example only; not an official policy/guidance ? ICH 2015

3

Q3D training module 5 Risk Assessment

Overview

? Potential sources of elemental impurities ? Risk assessment approaches ? Output of elemental risk assessment ? Product risk assessment Process

o Drug product based o Drug product component based

? Evaluation

Prepared by the Q3D Implementation Working Group for example only; not an official policy/guidance ? ICH 2015

4

Q3D training module 5 Risk Assessment

Elemental impurity risk assessment process

ICH Q3D defines a science and risk based assessment process to identify, evaluate, and define controls to limit elemental impurities in drug products

? Identify known and potential sources of elemental impurities that may find

their way into the drug product.

? Evaluate the presence of a particular elemental impurity in the drug

product by determining the observed or predicted level of the impurity and comparing with the established PDE.

? Summarize and document the risk assessment. Identify if controls built

into the process are sufficient or identify additional controls to be considered to limit elemental impurities in the drug product.

Prepared by the Q3D Implementation Working Group for example only; not an official policy/guidance ? ICH 2015

5

Q3D training module 5 Risk Assessment

Potential sources of elemental impurities

Excipients

Drug Substance

Elemental impurities in Drug Product

Utilities*

Manufacturing Equipment

Container Closure System

* Water is the primary utility of potential concern

The product assessment should consider the potential of each of these categories to contribute elemental impurities to the drug product

Prepared by the Q3D Implementation Working Group for example only; not an official policy/guidance ? ICH 2015

6

Q3D training module 5 Risk Assessment

Risk assessment approaches

? Examples of general approaches that may be considered during elemental

impurities risk assessment are:

o These approaches or others may change as information becomes available or additional experience is gained.

? Assessment of potential elemental impurities in the drug product

o Determine or assess the levels of elemental impurities in the final drug product o Depending on the formulation type, an evaluation from the container closure system may also be

required

? Assessment of potential elemental impurities from each component of the

drug product (API, excipients, container closure system)

o Assess each component for potential sources of elemental impurities o Identify known or likely elemental impurities o Determine the contribution of each component or source of elemental impurity to the levels in the

final drug product

? Irrespective of the approach chosen ? consider the elemental impurity

classification and recommendations in Table 5-1 (see following slide)

Prepared by the Q3D Implementation Working Group for example only; not an official policy/guidance ? ICH 2015

7

Q3D training module 5 Risk Assessment

Q3D Table 5-1: Elements to be considered in the risk assessment

Reference this table in the summary of the risk assessment.

Prepared by the Q3D Implementation Working Group for example only; not an official policy/guidance ? ICH 2015

8

 ................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download